POD-1 binding to the E-box sequence inhibits SF-1 and StAR expression in human adrenocortical tumor cells

Monica Malheiros França1, Bruno Ferraz-de-Souza, Mariza Gerdulo Santos

  • 1Department of Anatomy, Institute of Biomedical Sciences, University of São Paulo, São Paulo 05508-900, SP, Brazil.

Insights

Pod-1/Tcf21 inhibits Steroidogenic Factor-1 (SF-1) expression in adrenocortical tumor cells, impacting SF-1 target genes like StAR. Overexpression of POD-1 did not affect cell viability but correlated with cell cycle pathways in human ACCs.

Area of Science:

  • Endocrinology
  • Molecular Biology
  • Oncology

Background:

  • Pod-1/Tcf21 is involved in organ development and known to inhibit Steroidogenic Factor-1 (SF-1) during gonadal development.
  • SF-1 disruption causes adrenal disorders, while its overexpression is linked to adrenal cell proliferation and tumorigenesis.

Purpose of the Study:

  • To investigate if POD-1 overexpression inhibits endogenous SF-1 expression in human and mouse adrenocortical tumor cells.
  • To determine the effect of POD-1 on SF-1 target genes and cell cycle pathways in adrenocortical carcinoma (ACC).

Main Methods:

  • Transient transfection of adrenocortical cells (mouse Y-1, human H295R, ACC-T36) with POD-1 expression vectors and SF-1 promoter-luciferase reporter.
  • Chromatin immunoprecipitation (ChIP) assay to confirm POD-1 binding to the SF-1 promoter.
  • Analysis of SF-1 target gene StAR expression and correlation of POD-1/TCF21 with KEGG pathways in human ACCs.

Main Results:

  • POD-1 inhibited SF-1 promoter-driven luciferase reporter gene transcription in a dose-dependent manner.
  • POD-1 overexpression suppressed endogenous SF-1 expression in human and mouse ACC cells.
  • ChIP assay confirmed POD-1 binding to the E-box sequence in the SF-1 promoter.
  • POD-1 overexpression decreased the expression of the SF-1 target gene, StAR.
  • Induced POD-1 expression did not affect cell viability but was negatively correlated with cell cycle genes in human ACCs.

Conclusions:

  • POD-1/Tcf21 acts as a transcriptional repressor of SF-1 in adrenocortical tumor cells.
  • POD-1 influences SF-1-mediated pathways, including StAR expression, and is associated with cell cycle regulation in adrenocortical tumors.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Cell Specific Gene Expression01:58

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
NF-kB-dependent Signaling Pathway02:26

NF-kB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Cushing Syndrome II: Pathophysiology01:19

Cushing Syndrome II: Pathophysiology

Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...